Epigentek Home
 
EpiGentek Guarantee

ACVR1B Polyclonal Antibody

new product
Share:

Write a Review
Application: WB
Areas of Research: Cell Surface Receptor & Kinase Antibodies
Clonality: Polyclonal
Conjugate: Unconjugated
Host: Rabbit
Isotype: IgG
Purification: Affinity Purified
Reactivity: Human
100% Guarantee: 6 months
Catalog No.SizePriceQty
A71893-05050 µl $256.00 
A71893-100100 µl $359.00 
Why EpiGentek AntibodiesFree Shipping on Antibodies
Order now & get it by Friday, November 15th  
Product Overview

Background
This gene encodes an activin A type IB receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I and two type II receptors. This protein is a type I receptor which is essential for signaling. Mutations in this gene are associated with pituitary tumors. Alternate splicing results in multiple transcript variants.

Description
ACVR1B Polyclonal Antibody. Unconjugated. Raised in: Rabbit.

Formulation
Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

Specificity
Human

Isotype
IgG

Uniprot ID
P36896

Purification
Affinity Purification

Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 24-126 of human ACVR1B (NP_004293.1).

Storage
Shipped at 4°C. Upon receipt, store at -20°C. Avoid freeze / thaw cycles

Alternative Names
ACVR1B; ACTRIB; ACVRLK4; ALK4; SKR2; activin receptor type-1B

Application
WB; Recommended dilution: WB 1:500 - 1:2000

User Guide & MSDS

[User Guide]*
*Always use the actual User Guide that shipped with your product. Is the above file locked? You can also request user guides by emailing info@epigentek.com along with your contact information and institution name.

BisulPlus Loci 5mC & 5hmC Detection PCR kit
Terms & Conditions | Privacy Policy | Site Map
Copyright © 2019 EpiGentek Group Inc. All rights reserved.